Sputnik Light, the single-dose Covid-19 vaccine, can submit Russian safety data for approval in India, Dr Reddy's Laboratories said on Thursday.

The Hyderabad-based Dr Reddy's, in a statement, said that the Subject Expert Committee (SEC) under Drugs Controller General of India (DCGI) asked it to submit safety, immunogenicity and efficacy data from the Phase 3 clinical trial of Sputnik Light in Russia for consideration of marketing authorisation of Sputnik Light in India.